American Well Corporation (NYSE:AMWL) Receives Consensus Rating of “Hold” from Brokerages

American Well Corporation (NYSE:AMWL) has been given a consensus rating of “Hold” by the seven research firms that are currently covering the firm, MarketBeat.com reports. Six research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12 month price objective among analysts that have covered the stock in the last year is $9.1667.

AMWL has been the topic of a number of recent research reports. UBS Group dropped their price target on American Well from $12.00 to $9.00 and set a “neutral” rating on the stock in a research report on Thursday, May 8th. Wells Fargo & Company dropped their price target on American Well from $15.00 to $12.00 and set an “overweight” rating on the stock in a research report on Thursday, August 7th. Finally, Piper Sandler reaffirmed a “neutral” rating and set a $8.00 price target (down previously from $10.00) on shares of American Well in a research report on Friday, May 23rd.

American Well Price Performance

Shares of NYSE AMWL opened at $6.99 on Tuesday. American Well has a one year low of $6.09 and a one year high of $12.95. The business’s fifty day moving average price is $7.78 and its 200-day moving average price is $7.76. The stock has a market capitalization of $112.81 million, a PE ratio of -0.87 and a beta of 1.27.

American Well (NYSE:AMWL) last issued its quarterly earnings results on Tuesday, August 5th. The company reported ($1.24) EPS for the quarter, beating analysts’ consensus estimates of ($1.84) by $0.60. American Well had a negative return on equity of 41.99% and a negative net margin of 46.15%.The firm had revenue of $70.90 million for the quarter, compared to analysts’ expectations of $63.87 million. American Well has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, equities analysts expect that American Well will post -9.34 EPS for the current fiscal year.

Insider Transactions at American Well

In related news, Director Deborah C. Jackson sold 4,531 shares of the stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $7.10, for a total transaction of $32,170.10. Following the sale, the director owned 48,194 shares of the company’s stock, valued at approximately $342,177.40. This represents a 8.59% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Phyllis Gotlib sold 4,958 shares of the stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $8.63, for a total value of $42,787.54. Following the sale, the insider directly owned 136,891 shares in the company, valued at $1,181,369.33. This trade represents a 3.50% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 9,820 shares of company stock worth $77,814 in the last three months. 12.80% of the stock is currently owned by insiders.

Institutional Trading of American Well

A number of institutional investors have recently added to or reduced their stakes in AMWL. Goldman Sachs Group Inc. lifted its holdings in American Well by 280.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 64,760 shares of the company’s stock worth $510,000 after purchasing an additional 47,745 shares in the last quarter. Jane Street Group LLC lifted its holdings in American Well by 232.9% during the 1st quarter. Jane Street Group LLC now owns 64,112 shares of the company’s stock worth $505,000 after purchasing an additional 44,852 shares in the last quarter. Acadian Asset Management LLC lifted its holdings in American Well by 19.5% during the 1st quarter. Acadian Asset Management LLC now owns 188,217 shares of the company’s stock worth $1,481,000 after purchasing an additional 30,669 shares in the last quarter. Norges Bank purchased a new stake in American Well during the 2nd quarter worth about $250,000. Finally, Bridgeway Capital Management LLC lifted its holdings in American Well by 39.4% during the 4th quarter. Bridgeway Capital Management LLC now owns 96,741 shares of the company’s stock worth $701,000 after purchasing an additional 27,343 shares in the last quarter. Hedge funds and other institutional investors own 56.05% of the company’s stock.

American Well Company Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.